PASITHEA THERAPEUTICS CORP.

(KTTA)
  Report
Delayed Nasdaq  -  05/23 01:27:02 pm EDT
0.9000 USD   +0.56%
05/16PASITHEA THERAPEUTICS CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/16Pasithea Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/14Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2021 2022 2023
Capitalization1 38,720,8-
Enterprise Value (EV)1 -14,220,820,8
P/E ratio ---
Yield ---
Capitalization / Revenue 2 573x8,34x4,17x
EV / Revenue 2 573x8,34x4,17x
EV / EBITDA -8,60x-4,01x-4,17x
Price to Book ---
Nbr of stocks (in thousands) 21 88823 288-
Reference price (USD) 1,770,900,90
Announcement Date 03/30/2022--
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023
Net sales1 -0,022,505,00
EBITDA1 --4,51-5,20-5,00
Operating profit (EBIT) --4,51--
Operating Margin --29 930%--
Pre-Tax Profit (EBT) ----
Net income -0,04---
Net margin ----
EPS ----
Dividend per Share ----
Announcement Date 04/13/202103/30/2022--
1 USD in Million
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 0,020,010,500,801,00
EBITDA1 --2,40-1,20-1,20-1,20
Operating profit (EBIT) -1,96----
Operating Margin -12 990%----
Pre-Tax Profit (EBT) -----
Net income -----
Net margin -----
EPS -----
Dividend per Share -----
Announcement Date 03/30/202205/16/2022---
1 USD in Million
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023
Net Debt ----
Net Cash position -53,0--
Leverage (Debt / EBITDA) -11,8x--
Free Cash Flow --3,20--
ROE (Net Profit / Equities) ----
Shareholders' equity ----
ROA (Net Profit / Asset) ----
Assets ----
Book Value Per Share ----
Cash Flow per Share ----
Capex -0,02--
Capex / Sales -143%--
Announcement Date 04/13/202103/30/2022--
Estimates
Key data
Capitalization (USD) 20 842 597
Net sales (USD) 15 060
Number of employees 4
Sales / Employee (USD) 3 765
Free-Float 90,3%
Free-Float capitalization (USD) 18 822 928
Avg. Exchange 20 sessions (USD) 128 181
Average Daily Capital Traded 0,61%
EPS & Dividend